Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Plus Therapeutics donates personal protective equipment to Scripps Health » 07:21
04/06/20
04/06
07:21
04/06/20
07:21
PSTV

Plus Therapeutics

$1.41 /

-0.16 (-10.19%)

Plus Therapeutics…

Plus Therapeutics announced that it is donating personal protective equipment to San Diego's Scripps Health for distribution to its front-line doctors, nurses and other health-care practitioners caring for patients affected by the COVID-19 pandemic. The Company said that it has tapped its own medical supplies to deliver 250 surgical face masks directly to Scripps Health, which has an immediate and critical need for the protective gear for its health care professionals.

Hot Stocks
Plus Therapeutics appoints Gregory Stein as head of clinical development » 07:07
04/01/20
04/01
07:07
04/01/20
07:07
PSTV

Plus Therapeutics

$1.86 /

-0.38 (-16.96%)

Plus Therapeutics…

Plus Therapeutics announced that Dr. Gregory Stein has joined the Company as SVP of Clinical Development. Most recently he co-founded and served as CEO at Curtana Pharmaceuticals, which develops drugs for the treatment of glioblastoma and other brain cancers.

On The Fly
Fly Intel: Pre-market Movers » 09:20
03/30/20
03/30
09:20
03/30/20
09:20
JNJ

Johnson & Johnson

$123.28 /

-3.31 (-2.61%)

, ABT

Abbott

$74.52 /

-1.23 (-1.62%)

, SNY

Sanofi

$42.47 /

-0.48 (-1.12%)

, PSTV

Plus Therapeutics

$1.42 /

+0.09 (+6.77%)

, OMI

Owens & Minor

$5.51 /

-0.035 (-0.63%)

, HEXO

Hexo

$1.10 /

+0.075 (+7.35%)

, AXSM

Axsome Therapeutics

$63.27 /

-0.17 (-0.27%)

, MITT

AG Mortgage

$4.02 /

-0.06 (-1.47%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
JNJ Johnson & Johnson
$123.28 /

-3.31 (-2.61%)

03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/18/20 Cantor Fitzgerald
Cantor Fitzgerald says J&J is top idea in large cap pharma space
03/11/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Genmab following J&J drug announcement
03/06/20 Credit Suisse
Johnson & Johnson price target lowered to $159 from $170 at Credit Suisse
ABT Abbott
$74.52 /

-1.23 (-1.62%)

03/13/20 Wells Fargo
Wells says Abbott court win over Edwards in U.K. positive, but not a surprise
03/06/20 Credit Suisse
Abbott price target lowered to $94 from $104 at Credit Suisse
03/04/20 Citi
Abbott initiated with a Buy at Citi
02/19/20 Piper Sandler
New partnerships expected, but positive, for Insulet, says Piper Sandler
SNY Sanofi
$42.47 /

-0.48 (-1.12%)

03/27/20 Roth Capital
Roth Capital highlights Translate Bio's scalable mRNA platform
03/17/20 Barclays
Sanofi upgraded to Equal Weight from Underweight at Barclays
03/11/20 Oppenheimer
Regeneron price target raised to $525 from $450 at Oppenheimer
03/10/20 Goldman Sachs
Sanofi upgraded to Buy from Neutral at Goldman Sachs
PSTV Plus Therapeutics
$1.42 /

+0.09 (+6.77%)

OMI Owens & Minor
$5.51 /

-0.035 (-0.63%)

01/21/20 Baird
Owens & Minor upgraded to Outperform at Baird
01/21/20 Baird
Owens & Minor upgraded to Outperform from Neutral at Baird
HEXO Hexo
$1.10 /

+0.075 (+7.35%)

03/18/20 BMO Capital
Hexo downgraded to Underperform from Market Perform at BMO Capital
03/18/20 AltaCorp
Hexo downgraded to Underperform from Sector Perform at AltaCorp
03/09/20 Stifel
Stifel starts Hexo at Sell given 'precarious' Canadian cannabis position
02/21/20 Jefferies
Jefferies cuts Hexo to Underperform, says cannabis consensus still too high
AXSM Axsome Therapeutics
$63.27 /

-0.17 (-0.27%)

01/14/20 Ladenburg
Axsome Therapeutics price target raised to $165 from $139 at Ladenburg
12/31/19 SunTrust
Axsome Therapeutics price target raised to $140 from $100 at SunTrust
12/30/19 BTIG
Axsome Therapeutics price target raised to $114 from $97 at BTIG
12/30/19 Ladenburg
Axsome Therapeutics price target raised to $165 from $139 at Ladenburg
MITT AG Mortgage
$4.02 /

-0.06 (-1.47%)

Hot Stocks
Plus Therapeutics licenses oncology platform, expands pipeline » 07:45
03/30/20
03/30
07:45
03/30/20
07:45
PSTV

Plus Therapeutics

$1.42 /

+0.09 (+6.77%)

Plus Therapeutics…

Plus Therapeutics announced that it has entered into a definitive agreement to license multiple rare cancer drug product candidates from private Texas-based radiotherapeutic company NanoTx Therapeutics. The transaction terms include an upfront payment of $400,000 in cash and $300,000 in Plus voting stock. Furthermore, the company may pay up to $136.5 million in development and sales milestone payments and a tiered single-digit royalty on U.S. and European sales. The transaction, subject to customary closing conditions, is expected to close in the second quarter of fiscal 2020. The licensed drug portfolio is anchored around nanoliposome-encapsulated radionuclides for several cancer targets. The lead drug asset is a chelated Rhenium NanoLiposome, initially being developed for recurrent glioblastoma. RNL is infused directly into the brain tumor via precision brain mapping and convection enhanced delivery technology to deliver very high therapeutic doses of radiation to patients whose cancer has recurred following initial surgical resection and treatment with chemotherapy and radiation. The licensed radiolabeled nanoliposome platform was developed by a multi-institutional consortium based in Texas at the Mays Cancer Center / UT Health San Antonio MD Anderson Cancer Center led by Dr. Andrew Brenner, MD, PhD, who is the Kolitz Chair in Neuro-Oncology Research and Co-Leader of the Experimental and Developmental Therapeutics Program. The licensed technology was previously funded by both the National Institutes of Health/National Cancer Institute and the Cancer Prevention and Research Institute of Texas. There is an active $3M award from NIH/NCI which will financially support the continued clinical development of RNL for recurrent glioblastoma. Plus Therapeutics is licensing multiple BMEDA-chelated rhenium nanoliposome product candidates as part of this transaction. The lead drug asset is being developed for recurrent glioblastoma, a rare, incurable, and fatal disease. A Phase 1, dose-finding trial is ongoing at the Mays Cancer Center where 13 patients have been enrolled to-date. Thus far, no serious adverse events have occurred, and further dose escalation is planned. A similar product candidate is in preclinical development for several additional indications including breast cancer, head and neck cancer, leptomeningeal carcinomatosis, liver cancer, and ovarian cancers. Additionally, Plus Therapeutics is licensing a second preclinical product candidate, a co-encapsulated doxorubicin and BMEDA-chelated Rhenium NanoLiposome for treating squamous cell carcinoma of the head and neck. These licensed assets are supported by 19 preclinical publications. Plus Therapeutics' growing pipeline will feature product candidates characterized by previously approved small molecules or widely-used radionuclides, enhanced with delivery and formulation innovations, each potentially eligible for U.S. FDA and European Medicines Agency designations intended to expedite development and application review.

ShowHide Related Items >><<
Hot Stocks
Plus Therapeutics appoints Robert Lenk, Howard Clowes to board » 08:10
03/12/20
03/12
08:10
03/12/20
08:10
PSTV

Plus Therapeutics

$1.48 /

-0.28 (-15.91%)

Plus Therapeutics…

Plus Therapeutics announced that Dr. Robert Lenk and Mr. Howard Clowes will join the Company's Board of Directors to serve as independent directors, effective April 1, 2020. Dr. Lenk has over 35 years as pharmaceutical executive with deep expertise in nanoparticle drug development and drug formulation. He is currently President of Lenk Pharmaceuticals, a pharmaceuticals development consultant to multinational corporations and startups. A retired partner after nearly four decades at DLA Piper, a leading law firm, Mr. Clowes has served in leadership positions in the firm's Corporate and Securities Practice, advising public and private companies on securities law, financing, Mergers and Acquisition and general corporate matters.

Hot Stocks
Plus Therapeutics appoints Andrew Sims CFO » 09:36
02/07/20
02/07
09:36
02/07/20
09:36
PSTV

Plus Therapeutics

$2.21 /

-0.05 (-2.21%)

Plus Therapeutics…

Plus Therapeutics announced that Andrew Sims has been appointed as the company's CFO, effective February 5. A seasoned financial executive with two decades of leadership experience in North America, Europe and Asia, Mr. Sims has held senior management positions in numerous growth companies. In his new role at Plus Therapeutics, Mr. Sims will oversee the company's financial management and strategy, and will report to Dr. Marc Hedrick, the company's President and Chief Executive Officer. Sims arrives at Plus Therapeutics having previously held Chief Financial Officer roles at several private equity-backed companies. His focus has been on mergers and acquisitions, integrations, corporate capitalization, and building out and managing teams to support global growth.

Hot Stocks
Plus Therapeutics announces Greg Petersen joining board » 17:08
02/06/20
02/06
17:08
02/06/20
17:08
PSTV

Plus Therapeutics

$2.21 /

-0.05 (-2.21%)

Plus…

Plus Therapeutics,announced that Greg Petersen has joined the Company's Board of Directors to serve as an independent director, effective February 14. Greg will serve on the Audit and Compensation Committees. In addition, on January 31, 2020, Gregg Lapointe, submitted his resignation from the board of directors."We are happy that Greg Petersen has agreed to join our Board of Directors," said Dr. Marc Hedrick, President and CEO of Plus Therapeutics. "Greg is a seasoned public company Chief Financial Officer and board member having served those positions for a number of high growth companies over his career. More specifically, Greg has extensive experience in both audit and compensation matters and will serve on both of these committees on our Board of Directors."

Conference/Events
EBDF Group to hold a conference » 04:55
01/15/20
01/15
04:55
01/15/20
04:55
A

Agilent

$88.02 /

+0.565 (+0.65%)

, AGE

AgeX Therapeutics

$1.85 /

+0.13 (+7.56%)

, ALNY

Alnylam

$118.48 /

+3.68 (+3.21%)

, AZN

AstraZeneca

$50.18 /

+0.5 (+1.01%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.34 /

-0.04 (-0.91%)

, ENTX

Entera Bio

$2.78 /

-0.03 (-1.07%)

, DYAI

Dyadic International

$5.50 /

-0.135 (-2.40%)

, DTIL

Precision BioSciences

$13.40 /

-0.12 (-0.89%)

, DD

DuPont

$60.16 /

-0.25 (-0.41%)

, CYCC

Cyclacel Pharmaceuticals

$0.74 /

-0.0549 (-6.91%)

, CTLT

Catalent

$60.34 /

+0.88 (+1.48%)

, COWN

Cowen Group

$16.34 /

-0.2 (-1.21%)

, GMAB

Genmab

$22.44 /

-0.21 (-0.93%)

, IDXG

Interpace Biosciences

$0.62 /

+ (+0.00%)

, LCTX

Lineage Cell Therapeutics

$0.75 /

-0.0146 (-1.92%)

, PHIO

Phio Pharmaceuticals

$0.20 /

+0.0117 (+6.35%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.48 /

+0.03 (+2.07%)

, TROV

Changed name to CRDF

$1.47 /

+0.15 (+11.41%)

, VCYT

Veracyte

$28.58 /

+0.17 (+0.60%)

, VIE

Viela Bio

$37.10 /

+4.17 (+12.66%)

, PSTV

Plus Therapeutics

$2.81 /

+0.02 (+0.72%)

, RDUS

Radius Health

$20.14 /

+1.77 (+9.64%)

, MRNA

Moderna

$20.01 /

-0.21 (-1.04%)

, MRK

Merck

$89.93 /

+0.5 (+0.56%)

, NAVB

Navidea

$1.49 /

-0.03 (-1.97%)

, NBSE

NeuBase Therapeutics

$6.31 /

-0.19 (-2.92%)

, NVO

Novo Nordisk

$59.62 /

+0.66 (+1.12%)

, NVS

Novartis

$94.47 /

+0.765 (+0.82%)

, OVID

Ovid Therapeutics

$3.59 /

+0.09 (+2.57%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$7.20 /

+0.46 (+6.82%)

, SLRX

Salarius Pharmaceuticals

$3.20 /

+0.15 (+4.92%)

, VVUS

VIVUS

$2.72 /

-0.01 (-0.37%)

, SIVB

SVB Financial

$253.42 /

-0.36 (-0.14%)

, VRML

Vermillion

$0.79 /

-0.0453 (-5.39%)

, VKTX

Viking Therapeutics

$7.36 /

+0.045 (+0.62%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$88.02 /

+0.565 (+0.65%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.85 /

+0.13 (+7.56%)

ALNY Alnylam
$118.48 /

+3.68 (+3.21%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$50.18 /

+0.5 (+1.01%)

01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
01/13/20 JPMorgan
Epanova discontinuation positive for Amarin, says JPMorgan
12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.34 /

-0.04 (-0.91%)

ENTX Entera Bio
$2.78 /

-0.03 (-1.07%)

DYAI Dyadic International
$5.50 /

-0.135 (-2.40%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$13.40 /

-0.12 (-0.89%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$60.16 /

-0.25 (-0.41%)

01/14/20
Fly Intel: Top five analyst initiations
01/14/20 BMO Capital
DuPont price target lowered to $82 from $87 at BMO Capital
01/14/20 Gordon Haskett
DuPont initiated with a Buy at Gordon Haskett
01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
CYCC Cyclacel Pharmaceuticals
$0.74 /

-0.0549 (-6.91%)

CTLT Catalent
$60.34 /

+0.88 (+1.48%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.34 /

-0.2 (-1.21%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.44 /

-0.21 (-0.93%)

01/13/20 SunTrust
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.62 /

+ (+0.00%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.75 /

-0.0146 (-1.92%)

PHIO Phio Pharmaceuticals
$0.20 /

+0.0117 (+6.35%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.48 /

+0.03 (+2.07%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.47 /

+0.15 (+11.41%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.58 /

+0.17 (+0.60%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$37.10 /

+4.17 (+12.66%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.81 /

+0.02 (+0.72%)

RDUS Radius Health
$20.14 /

+1.77 (+9.64%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$20.01 /

-0.21 (-1.04%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.93 /

+0.5 (+0.56%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.49 /

-0.03 (-1.97%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$6.31 /

-0.19 (-2.92%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$59.62 /

+0.66 (+1.12%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 SunTrust
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$94.47 /

+0.765 (+0.82%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.59 /

+0.09 (+2.57%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$7.20 /

+0.46 (+6.82%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.20 /

+0.15 (+4.92%)

VVUS VIVUS
$2.72 /

-0.01 (-0.37%)

SIVB SVB Financial
$253.42 /

-0.36 (-0.14%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 SunTrust
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.79 /

-0.0453 (-5.39%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.36 /

+0.045 (+0.62%)

11/21/19 SunTrust
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Conference/Events
EBDF Group to hold a conference » 04:55
01/14/20
01/14
04:55
01/14/20
04:55
A

Agilent

$87.45 /

-0.19 (-0.22%)

, AGE

AgeX Therapeutics

$1.72 /

-0.15 (-8.02%)

, ALNY

Alnylam

$114.80 /

-4.57 (-3.83%)

, AZN

AstraZeneca

$49.68 /

-0.17 (-0.34%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.38 /

+0.01 (+0.23%)

, ENTX

Entera Bio

$2.81 /

+0.13 (+4.85%)

, DYAI

Dyadic International

$5.64 /

-0.055 (-0.97%)

, DTIL

Precision BioSciences

$13.52 /

-1.19 (-8.09%)

, DD

DuPont

$60.41 /

+0.7 (+1.17%)

, CYCC

Cyclacel Pharmaceuticals

$0.80 /

-0.115 (-12.64%)

, CTLT

Catalent

$59.46 /

+1.77 (+3.07%)

, COWN

Cowen Group

$16.54 /

+0.24 (+1.47%)

, GMAB

Genmab

$22.65 /

-0.02 (-0.09%)

, IDXG

Interpace Biosciences

$0.62 /

-0.0289 (-4.45%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.002 (-0.26%)

, PHIO

Phio Pharmaceuticals

$0.18 /

-0.0225 (-10.95%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.45 /

-0.14 (-8.81%)

, TROV

Changed name to CRDF

$1.32 /

+0.075 (+6.05%)

, VCYT

Veracyte

$28.41 /

-0.49 (-1.70%)

, VIE

Viela Bio

$32.93 /

+2.84 (+9.44%)

, PSTV

Plus Therapeutics

$2.79 /

-0.05 (-1.76%)

, RDUS

Radius Health

$18.37 /

-1.05 (-5.41%)

, MRNA

Moderna

$20.22 /

+1.12 (+5.86%)

, MRK

Merck

$89.43 /

-0.08 (-0.09%)

, NAVB

Navidea

$1.52 /

+ (+0.00%)

, NBSE

NeuBase Therapeutics

$6.50 /

-0.51 (-7.28%)

, NVO

Novo Nordisk

$58.96 /

+0.27 (+0.46%)

, NVS

Novartis

$93.71 /

-0.165 (-0.18%)

, OVID

Ovid Therapeutics

$3.50 /

-0.35 (-9.09%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.74 /

+0.3 (+4.66%)

, SLRX

Salarius Pharmaceuticals

$3.05 /

-0.58 (-15.98%)

, VVUS

VIVUS

$2.73 /

-0.065 (-2.33%)

, SIVB

SVB Financial

$253.78 /

+1.99 (+0.79%)

, VRML

Vermillion

$0.84 /

+0.036 (+4.48%)

, VKTX

Viking Therapeutics

$7.31 /

-0.4 (-5.19%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$87.45 /

-0.19 (-0.22%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.72 /

-0.15 (-8.02%)

ALNY Alnylam
$114.80 /

-4.57 (-3.83%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$49.68 /

-0.17 (-0.34%)

01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
01/13/20 JPMorgan
Epanova discontinuation positive for Amarin, says JPMorgan
12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.38 /

+0.01 (+0.23%)

ENTX Entera Bio
$2.81 /

+0.13 (+4.85%)

DYAI Dyadic International
$5.64 /

-0.055 (-0.97%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$13.52 /

-1.19 (-8.09%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$60.41 /

+0.7 (+1.17%)

01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
12/18/19 DZ Bank
DuPont upgraded to Buy from Hold at DZ Bank
12/17/19 JPMorgan
IFF shares can rally 50% over three years, says JPMorgan
12/17/19 Jefferies
DuPont price target lowered to $79 from $85 at Jefferies
CYCC Cyclacel Pharmaceuticals
$0.80 /

-0.115 (-12.64%)

CTLT Catalent
$59.46 /

+1.77 (+3.07%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.54 /

+0.24 (+1.47%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.65 /

-0.02 (-0.09%)

01/13/20 SunTrust
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.62 /

-0.0289 (-4.45%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.76 /

-0.002 (-0.26%)

PHIO Phio Pharmaceuticals
$0.18 /

-0.0225 (-10.95%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.45 /

-0.14 (-8.81%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.32 /

+0.075 (+6.05%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.41 /

-0.49 (-1.70%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$32.93 /

+2.84 (+9.44%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.79 /

-0.05 (-1.76%)

RDUS Radius Health
$18.37 /

-1.05 (-5.41%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$20.22 /

+1.12 (+5.86%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.43 /

-0.08 (-0.09%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.52 /

+ (+0.00%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$6.50 /

-0.51 (-7.28%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$58.96 /

+0.27 (+0.46%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 SunTrust
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$93.71 /

-0.165 (-0.18%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.50 /

-0.35 (-9.09%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$6.74 /

+0.3 (+4.66%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.05 /

-0.58 (-15.98%)

VVUS VIVUS
$2.73 /

-0.065 (-2.33%)

SIVB SVB Financial
$253.78 /

+1.99 (+0.79%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 SunTrust
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.84 /

+0.036 (+4.48%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.31 /

-0.4 (-5.19%)

11/21/19 SunTrust
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Conference/Events
EBDF Group to hold a conference » 08:42
01/13/20
01/13
08:42
01/13/20
08:42
A

Agilent

$87.64 /

+0.32 (+0.37%)

, AGE

AgeX Therapeutics

$1.87 /

-0.01 (-0.53%)

, ALNY

Alnylam

$119.37 /

+1.36 (+1.15%)

, AZN

AstraZeneca

$49.85 /

-0.24 (-0.48%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.37 /

+0.02 (+0.46%)

, ENTX

Entera Bio

$2.68 /

+0.08 (+3.08%)

, DYAI

Dyadic International

$5.69 /

+0.36 (+6.75%)

, DTIL

Precision BioSciences

$14.71 /

+0.02 (+0.14%)

, DD

DuPont

$59.71 /

-1.25 (-2.05%)

, CYCC

Cyclacel Pharmaceuticals

$0.91 /

+0.1578 (+20.98%)

, CTLT

Catalent

$57.69 /

+0.73 (+1.28%)

, COWN

Cowen Group

$16.30 /

-0.25 (-1.51%)

, GMAB

Genmab

$22.67 /

+ (+0.00%)

, IDXG

Interpace Biosciences

$0.65 /

+0.0189 (+3.00%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.018 (-2.31%)

, PHIO

Phio Pharmaceuticals

$0.21 /

-0.023 (-9.83%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.59 /

+ (+0.00%)

, TROV

Changed name to CRDF

$1.24 /

-0.02 (-1.59%)

, VCYT

Veracyte

$28.90 /

+0.45 (+1.58%)

, VIE

Viela Bio

$30.09 /

+1.07 (+3.69%)

, PSTV

Plus Therapeutics

$2.84 /

+0.13 (+4.80%)

, RDUS

Radius Health

$19.42 /

-1.07 (-5.22%)

, MRNA

Moderna

$19.10 /

+0.71 (+3.86%)

, MRK

Merck

$89.51 /

+0.11 (+0.12%)

, NAVB

Navidea

$1.52 /

+0.005 (+0.33%)

, NBSE

NeuBase Therapeutics

$7.01 /

-0.36 (-4.88%)

, NVO

Novo Nordisk

$58.69 /

+1.25 (+2.18%)

, NVS

Novartis

$93.87 /

-0.88 (-0.93%)

, OVID

Ovid Therapeutics

$3.85 /

-0.18 (-4.47%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.44 /

+0.14 (+2.22%)

, SLRX

Salarius Pharmaceuticals

$3.63 /

+0.03 (+0.83%)

, VVUS

VIVUS

$2.79 /

-0.03 (-1.06%)

, SIVB

SVB Financial

$251.79 /

-4.15 (-1.62%)

, VRML

Vermillion

$0.80 /

-0.016 (-1.95%)

, VKTX

Viking Therapeutics

$7.71 /

-0.02 (-0.26%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$87.64 /

+0.32 (+0.37%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.87 /

-0.01 (-0.53%)

ALNY Alnylam
$119.37 /

+1.36 (+1.15%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$49.85 /

-0.24 (-0.48%)

12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
12/19/19 Baird
AstraZeneca deal a 'landmark win' for Iqvia OCE solution, says Baird
12/19/19 KeyBanc
Iqvia win at AstraZeneca at loss for Veeva, says KeyBanc
12/16/19 Stifel
Stifel 'taking profits' on Amarin following FDA approval, downgrades to Hold
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.37 /

+0.02 (+0.46%)

ENTX Entera Bio
$2.68 /

+0.08 (+3.08%)

DYAI Dyadic International
$5.69 /

+0.36 (+6.75%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$14.71 /

+0.02 (+0.14%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$59.71 /

-1.25 (-2.05%)

01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
12/18/19 DZ Bank
DuPont upgraded to Buy from Hold at DZ Bank
12/17/19 JPMorgan
IFF shares can rally 50% over three years, says JPMorgan
12/17/19 Jefferies
DuPont price target lowered to $79 from $85 at Jefferies
CYCC Cyclacel Pharmaceuticals
$0.91 /

+0.1578 (+20.98%)

CTLT Catalent
$57.69 /

+0.73 (+1.28%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.30 /

-0.25 (-1.51%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.67 /

+ (+0.00%)

01/13/20 SunTrust
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.65 /

+0.0189 (+3.00%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.76 /

-0.018 (-2.31%)

PHIO Phio Pharmaceuticals
$0.21 /

-0.023 (-9.83%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.59 /

+ (+0.00%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.24 /

-0.02 (-1.59%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.90 /

+0.45 (+1.58%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$30.09 /

+1.07 (+3.69%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.84 /

+0.13 (+4.80%)

RDUS Radius Health
$19.42 /

-1.07 (-5.22%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$19.10 /

+0.71 (+3.86%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.51 /

+0.11 (+0.12%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.52 /

+0.005 (+0.33%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$7.01 /

-0.36 (-4.88%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$58.69 /

+1.25 (+2.18%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 SunTrust
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$93.87 /

-0.88 (-0.93%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.85 /

-0.18 (-4.47%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$6.44 /

+0.14 (+2.22%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.63 /

+0.03 (+0.83%)

VVUS VIVUS
$2.79 /

-0.03 (-1.06%)

SIVB SVB Financial
$251.79 /

-4.15 (-1.62%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 SunTrust
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.80 /

-0.016 (-1.95%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.71 /

-0.02 (-0.26%)

11/21/19 SunTrust
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.